XML 33 R46.htm IDEA: XBRL DOCUMENT v2.4.0.8
Schedule I - Condensed Financial Information of Registrant (Tables)
12 Months Ended
Dec. 31, 2013
SCHEDULE I - CONDENSED FINANCIAL INFORMATION OF REGISTRANT [Abstract]  
Schedule of Balance Sheet

 

 

December 31, 2012

 

December 31, 2013

 

 

 

(in U.S. dollars, except number of shares)

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

5,219,295

 

56,999

 

Prepaid expenses and other current assets

 

312,174

 

250,091

 

Amount due from subsidiaries and variable interest entities

 

3,003,202

 

15,709,401

 

Amount due from related parties

 

6,096,800

 

1,741,836

 

Total current assets

 

14,631,471

 

17,758,327

 

Investments in subsidiaries

 

21,046,640

 

8,082,866

 

Total assets

 

35,678,111

 

25,841,193

 

 

 

 

 

 

 

Liabilities and shareholders’ equity

 

 

 

 

 

Accrued expenses and other current liabilities

 

664,896

 

701,375

 

Amounts due to subsidiaries and variable interest entities

 

1,071,669

 

24,711,656

 

Amount due to related parties

 

375,000

 

375,000

 

Total current liabilities

 

2,111,565

 

25,788,031

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

Ordinary shares ($0.00005 par value; 12,000,000,000 shares authorized; 4,732,446,560 and 4,730,648,360 shares issued and outstanding as of December 31, 2012 and 2013, respectively)

 

236,575

 

236,485

 

Additional paid-in capital

 

177,182,895

 

178,195,109

 

Accumulated deficit

 

(141,940,509

)

(176,368,243

)

Accumulated other comprehensive loss

 

(1,912,415

)

(2,010,189

)

Total shareholders’ equity

 

33,566,546

 

53,162

 

Total liabilities and shareholders’ equity

 

35,678,111

 

25,841,193

 

Schedule of Statement of Operations

 

 

Year ended
December 31, 2011

 

Year ended
December 31, 2012

 

Year ended
December 31, 2013

 

 

 

(in U.S. dollars, except number of shares)

 

Operating expenses:

 

 

 

 

 

 

 

Product development

 

603,879

 

278,168

 

269,876

 

Selling and marketing

 

(31,880

)

30,773

 

54,503

 

General and administrative

 

2,433,905

 

1,119,757

 

1,403,657

 

Total operating expenses

 

3,005,904

 

1,428,698

 

1,728,036

 

Loss from operations

 

(3,005,904

)

(1,428,698

)

(1,728,036

)

Interest income

 

112,416

 

349,525

 

30,483

 

Interest expense

 

(375,000

)

 

 

Other expense

 

 

 

(739,530

)

Foreign exchange (loss) / gain

 

(9

)

(15,589

)

355,337

 

Equity in losses of subsidiaries

 

(46,075,410

)

(8,396,376

)

(32,345,988

)

Net loss

 

(49,343,907

)

(9,491,138

)

(34,427,734

)

Schedule of Statements of Cash Flows

 

 

Year ended
December 31, 2011

 

Year ended
 December 31, 2012

 

Year ended
December 31, 2013

 

 

 

(in U.S. dollars, except number of shares)

 

Operating activities:

 

 

 

 

 

 

 

Net loss

 

(49,343,907

)

(9,491,138

)

(34,427,734

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

Share-based compensation

 

1,231,919

 

463,753

 

1,023,871

 

Share-based compensation cost in relation to disposition of Yisheng

 

522,251

 

 

 

Provision for Seed Music receivable (related party)

 

 

 

980,000

 

Exchange gains

 

 

 

(355,337

)

Equity in losses of subsidiaries

 

46,075,410

 

8,396,376

 

32,345,988

 

Prepaid expenses and other current assets

 

(193,214

)

122,056

 

62,083

 

Amounts due from subsidiaries and variable interest entities

 

 

(1,645

)

 

Amount due from related parties

 

(1,692,875

)

(92,159

)

74,964

 

Other payables and accruals

 

(323,956

)

(277,527

)

36,479

 

Amounts due to subsidiaries and variable interest entities

 

(77,833

)

(4,013,840

)

4,160,000

 

Amounts due to related parties

 

375,000

 

 

 

Net cash provided by (used in) operating activities

 

(3,427,205

)

(4,894,124

)

3,900,314

 

 

 

 

 

 

 

 

 

Investing activities:

 

 

 

 

 

 

 

Loan to subsidiaries

 

(5,762,569

)

(3,001,557

)

(12,350,863

)

Loan to related parties

 

(14,108,019

)

(470,000

)

 

Repayment of loans from related parties under common control of Shanda

 

 

14,000,000

 

3,300,000

 

Investment in subsidiary

 

(30,000,000

)

 

 

Net cash provided by (used in) investing activities

 

(49,870,588

)

10,528,443

 

(9,050,863

)

 

 

 

 

 

 

 

 

Financing activities:

 

 

 

 

 

 

 

Proceeds from exercise of options

 

3,750

 

 

46,400

 

Proceeds from issuance of ordinary shares to Shanda

 

50,000,000

 

 

 

Proceeds from issuance of Convertible Bond to Shanda

 

50,000,000

 

 

 

Cash paid for redemption of Convertible Bond to Shanda

 

(50,000,000

)

 

 

Repurchase of ordinary shares

 

 

(8,169,481

)

(58,147

)

Net cash provided by (used in) financing activities

 

50,003,750

 

(8,169,481

)

(11,747

)

Effect of exchange rate changes on cash and cash equivalents

 

 

 

 

Net decrease in cash and cash equivalents

 

(3,294,043

)

(2,535,162

)

(5,162,296

)

Cash and cash equivalents, beginning of year

 

11,048,500

 

7,754,457

 

5,219,295

 

Cash and cash equivalents, end of year

 

7,754,457

 

5,219,295

 

56,999